Invention Grant
- Patent Title: Anti-N3pGlu amyloid beta peptide antibodies and uses thereof
- Patent Title (中): 抗N3pGlu淀粉样β肽抗体及其用途
-
Application No.: US14039113Application Date: 2013-09-27
-
Publication No.: US08961972B2Publication Date: 2015-02-24
- Inventor: Jirong Lu , Ying Tang , Ronald Bradley Demattos
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Sanjay M. Jivraj
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K39/395 ; G01N33/577 ; A61K39/00
Abstract:
The present invention provides anti-N3pGlu Aβ antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu Aβ antibodies or antigen-binding fragment thereof for the treatment of Alzheimer's disease.
Public/Granted literature
- US20140065138A1 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF Public/Granted day:2014-03-06
Information query
